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Introduction: Aortic intramural hematoma type B (IMHB) is a variant of acute aortic syndrome, which presents with
symptoms similar to classic type B aortic dissection (ABAD). However, the natural history of IMHB is not well
understood. The purpose of this study was to better characterize IMHB, comparing its clinical characteristics, treatment,
and in-hospital and long-term outcomes to those with classic ABAD.
Methods: A total of 107 IMHB and 790 ABAD patients enrolled in the International Registry of Acute Aortic Dissection
(IRAD) between January 1996 and June 2012 were analyzed. Accordingly, differences in presentation, diagnostics,
therapeutic management, and outcomes were assessed.
Results: As compared with the ABAD, IMHB presented predominantly in males (62% vs 33%; P < .001) at older age (696
12 vs 63 6 14; P < .001). IMHB patients more often had chest pain (80% vs 69%; P [ .020) and periaortic hematoma
(22% vs 13%; P [ .020) and were more often treated medically (88% vs 62%; P < .001), with surgical/endovascular
interventions being reserved for more complicated patients. Overall in-hospital mortality was 10% (IMHB, 7% vs ABAD,
11%; P [ NS). Six out of seven IMHB deaths occurred during medical treatment, two due to aortic rupture. During
follow-up in IMHB, patient mortality was 7%, and no adverse events, including progression to an aortic dissection or
aortic rupture, were observed. Imaging showed signiﬁcantly more aortic enlargement at the level of the descending aorta
in ABAD patients (39% vs 61%; P [ .034).
Conclusions: Most IMHB patients can be treated medically, and aortic enlargement is less common during follow-up,
which may suggest that IMHB may have a slightly more benign course compared with classic ABAD in the acute set-
ting. (J Vasc Surg 2013;58:1498-504.)Aortic intramural hematoma type B (IMHB) is a
serious aortic condition characterized by a crescentic thick-
ening of the descending aorta in the absence of an intimal
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8aortic wall. Initially, it was believed that this condition
was relatively rare compared with classic type B aortic
dissections (ABAD), although presenting with similar
symptoms, morbidity, and mortality rates.1-4 However,
more recent studies suggest that the incidence of IMHB
is much higher and accounts for >20% of all ABAD in
some series.1,5-8
Althoughmost series report excellent results for medical
treatment of IMHB, the course of this disease remains vari-
able and unpredictable.1,5,8 Progression to a classic dissec-
tion is the most feared complication, and multiple studies
have focused on identifying high-risk patients.9,10 Age,
aortic diameter, and wall thickness have been identiﬁed as
potential risk factors, but these ﬁndings could not be
conﬁrmed by other studies.5,11,12 In this group of patients,
complications are rare, and therefore, many physicians
consider IMHB as a less hazardous disease, relying on
medical treatment combined with adequate follow-up. We
investigated the International Registry of Aortic Dissection
(IRAD) to assess the presentation, management, and
outcomes of IMHB compared with classic ABAD.
METHODS
Patient selection. We analyzed all patients enrolled in
the International Registry of Acute Aortic Dissection
Fig 1. A and B, Sagittal and transverse view of computed tomography angiogram showing an intramural hematoma of
the descending aorta. C andD, Sagittal and transverse view of computed tomography angiogram showing a classic type
B aortic dissection (ABAD).
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registry that enrolls patients with acute aortic dissection
at 30 large referral centers. Its inception and structure
have been described previously.13 Patient and procedural
data are collected using forms with more than 290 vari-
ables, which are submitted to the IRAD coordinating
center at the University of Michigan and checked for face
validity and analytical internal validity. All patients with
ABAD enrolled in IRAD from January 1996 to June 2012
were included in this analysis (n ¼ 897). In contrast to
prior IRAD studies on IMH, we included only those with
involvement of the descending and abdominal aorta.4,14
Therefore, those patients with proximal extension in the
aortic arch and ascending aorta were excluded from this
analysis. Based on imaging studies, patients were classiﬁed
as either classic ABAD or IMHB (Fig 1, A and B). IMHB
was considered when a crescentic thickening of the aortic
wall was identiﬁed on the ﬁrst or second imaging study
in the absence of any entry tear, double lumen, and/or
intimal ﬂap (Fig 1, C and D). In the case of concomitant
mention of both IMH and an intimal ﬂap or double lumen,
patients were assigned to the ABAD group. Patients withIMH were compared with those with ABAD with regard
to demographics, presenting signs, symptoms, manage-
ment, complications, and mortality.
Statistical analysis. The IMHB and ABAD groups
were contrasted utilizing c2 tests (and Fisher exact tests
where applicable) to analyze categorical variables. Student
t-test was used to analyze continuous variables, and the
nonparametric test of medians to analyze non-normally
distributed categorical variables. A P value <.05 was
considered signiﬁcant. Data analysis was performed with
the use of SPSS statistical analysis software (SPSS Inc,
Chicago, Ill).
RESULTS
Demographics and presenting symptoms. A total of
107 IMHB and 790 patients with a classic ABAD were
included in this analysis. In general, IMHB patients pre-
sented at an older age (69 6 12 vs 63 6 14; P < .001)
and were predominantly male (62%; Table I). Marfan
syndrome and prior aortic dissection were more common
in the ABAD group. Atherosclerosis was present in 27% of
IMHB patients, which was comparable with ABAD
Table I. Demographics for IMHB and ABAD patients
Category
Type B
IMHB,
No. (%)
ABAD,
No. (%) P value
Type B, No. 107 790
Mean age 6 SD, years 69 6 12 63 6 14 <.001
Gender, male 66 (62) 262 (33) .290
Race, nonwhite 10 (10) 127 (17) .058
Patient was transferred 63 (59) 575 (73) .003
North American site 52 (49) 466 (59) .041
European site 53 (50) 289 (37) .010
Enrollment: U.S. site vs
European site
36 (40) 430 (60) <.001
ABAD, Type B aortic dissection; IMHB, aortic intramural hematoma type B;
SD, standard deviation.
Data are presented as number (%) unless otherwise indicated.
Table II. Patient history for IMHB and ABAD patients
Category
Type B
IMHB,
No. (%)
ABAD,
No. (%) P value
Hypertension 84 (79) 623 (80) .900
Diabetes 10 (10) 58 (8) .477
Marfan syndrome 0 (0) 29 (4) .039
Atherosclerosis 28 (27) 239 (31) .374
Known aortic aneurysm 16 (15) 153 (20) .264
Prior aortic dissection 1 (1) 75 (10) .001
Bicuspid aortic valve 0 (0) 16 (3) .243
Family history of aortic disease 4 (9) 29 (11) .798
ABAD, Type B aortic dissection; IMHB, aortic intramural hematoma type B.
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frequently present in IMHB patients (80% vs 69%; P ¼
.020). No differences in interval time between symptoms
and diagnosis were observed in the two groups. Two-thirds
of the patients presented with hypertension, which was not
different between groups (63% vs 69%; P ¼ .196). Pulse
deﬁcits were infrequently present in the IMHB group (6%
vs 19%; P < .001). Of the ﬁve IMHB patients with deﬁcits
noted, three patients presented with left brachial pulse
deﬁcit and two with a femoral pulse deﬁcit. No other
differences in presentation were observed between groups
(Table III).
Diagnostic imaging ﬁndings. Computed tomog-
raphy was the most commonly used diagnostic modality.
The frequency of the performed diagnostic tests was
comparable between groups for all modalities (Table IV).
Signiﬁcantly more IMHB patients presented with peri-
aortic hematoma, which was deﬁned as blood outside the
adventitia (22% vs 13%; P ¼ .020). The aortic diameter at
the level of the aortic root and sinotubular junction was
signiﬁcantly larger in ABAD patients, being 3.6 cm
(interquartile range [IQR], 3.3-4.0) vs 3.4 cm (IQR, 3.1-
3.9; P ¼ .047) and 3.4 cm (IQR, 3.0-3.8) vs 3.0 cm (IQR,
2.7-3.4; P ¼ .002), respectively. The maximum descending
aortic diameter was equal (both 4.0 cm). IHMB was more
frequently observed in referring centers compared with
tertiary centers (17% vs 9.9%; P ¼ .003). Abdominal
extension was more common in ABAD compared with
IMHB (64.9% vs 40.2%; P <.001).
Treatment. Treatment strategies and type of surgery
are presented in Table V. All participating centers used
a similar treatment algorithm consisting of initial medical
treatment and reserved surgical intervention for those
patients that develop aortic rupture, malperfusion, refrac-
tory hypertension, and/or refractory, recurrent pain. IMHB
patients were more often treated medically (88%) compared
with ABAD patients (62%; P < .001), while open surgery
was more frequently performed in ABAD (112 [14%] vs 5
[5%]; P ¼ .005). Indications for surgical intervention in theIMHB patients were the development of a classic dissection
in one patient, aortic rupture in one patient, and refractory/
recurrent pain in three patients. Endovascular management
was also more often adopted in ABAD (23% vs 7%; P <
.001). The indication for thoracic endovascular aneurysm
repair was unspeciﬁed in six uncomplicated IMHB patients,
and one IMHB patient had refractory pain.
Outcome and follow-up. Overall in-hospital mor-
tality was 10% (IMHB, 7% vs ABAD, 11%; P ¼ NS;
Table VI). Out of the seven IMHB patients who had in-
hospital mortality, six died during medical treatment,
and, among these, two developed a spontaneous aortic
rupture. One-year follow-up was available for 42% (45/
107) of the IMHB patients and for 34.7% (274/790) of
the ABAD patients. During this period, four patients (9%)
died in the IMHB group and 19 (7%) in the ABAD group,
of which only two patients died after open surgical treat-
ment. No adverse events, including progression to an aortic
dissection or aortic rupture, were observed during this
period. Follow-up imaging showed signiﬁcantly more
aortic enlargement at the level of the descending aorta in
ABAD patients (39% vs 61%; P ¼ .034). During follow-up,
nonsigniﬁcant changes in the types of antihypertensive
agent were made in the medical treatment of IMHB
patients. Kaplan-Meier showed no difference for the 5-year
survival between both groups (P ¼ NS; Fig 2).
DISCUSSION
This study provides insight in the clinical presentation
of IMHB and the current treatment strategies applied in
30 large referral centers. Our analysis showed that the
treatment differed signiﬁcantly between groups, with
IMHB more often treated successfully with medical
management. In addition, it suggests that IMHB affects
more frequently a limited segment of the descending aorta,
not extending in the abdomen as much as in ABAD
patients. One-year follow-up showed that IMHB patients
had less often aortic enlargement when compared with
ABAD and more frequently continued medical therapy.
In the literature, the incidence of IMHB in acute aortic
dissection patients varies between 2% and 45%, with
Table III. Presenting symptoms and complications for IMHB and ABAD patients
Category
Type B
IMHB, No. (%) ABAD, No. (%) P value
Chest pain 84 (80) 527 (68.9) .020
Back pain 84 (79) 527 (69.8) .064
Abdominal pain 36 (35) 325 (43.6) .097
Radiating pain 36 (35) 332 (44.9) .068
Migrating pain 21 (21) 131 (18.0) .530
Abrupt onset of pain 84 (82) 653 (87.4) .100
Presenting hypertensive 65 (63) 512 (68.8) .196
Presenting hypotensive 4 (4) 31 (4.2) 1.000
Presented with pulse deﬁcits 5 (5.6) 118 (19.1) .001
Median time from presentation to diagnosis, hours (Q1-Q3) 19 (14-37) 20 (13-27) .964
Complications:
Shock 0 (0) 9 (1) .259
Mesenteric ischemia/infarction 0 (0) 49 (7) .008
Spinal cord ischemia 0 (0) 12 (3) .201
Acute renal failure 9 (9) 115 (16) .086
Limb ischemia 0 (0) 75 (10) .001
Recurrent pain 2 (22) 59 (31) .594
Refractory pain 3 (33) 31 (16) .176
ABAD, Type B aortic dissection; IMHB, aortic intramural hematoma type B.
Data are presented as number (%) unless otherwise indicated.
Table IV. Imaging studies for diagnosis in IMHB and ABAD patients
Category
Type B
IMHB, No. (%) ABAD, No. (%) P value
Chest X ray showed abnormal aortic contour 43 (49) 259 (42) .169
Transesophageal echo done 57 (53) 360 (47) .185
Computed tomography done 105 (98) 746 (95) .219
Magnetic resonance imaging done 17 (16) 120 (16) .955
>1 imaging study performed 62 (60) 408 (56) .447
Imaging studies performed, No. (range) 2 (1-2) 2 (1-2) .167
IMH identiﬁed at referring hospital 52 (61) - -
IMH identiﬁed at tertiary hospital 33 (39) - -
Periaortic hematoma identiﬁed on any imaging study 21 (22) 92 (13) .020
ABAD, Type B aortic dissection; IMHB, aortic intramural hematoma type B.
Data are presented as number (%) unless otherwise indicated.
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The overall incidence of IMHB in our study was 12%,
with a signiﬁcantly higher incidence in European sites
compared with the United States (16% vs 8%; P < .001).
Genetic, dietary, or environmental inﬂuences might also
play a role in the geographic variation of IMHB, as the
literature suggests that the incidence is even higher in the
Asian population.6,7 A higher prevalence of type A IMH
has also been previously described at Asian sites. Due to
a relative underrepresentation of Asians in the IRAD
registry, our analysis could not conﬁrm such a difference.16
Nevertheless, these differences might result also from
a heightened awareness of this disease and differently
applied diagnostic modalities. In addition, there was a trend
toward an increased prevalence of Marfan syndrome in
ABAD patients compared with IMHB. The general
hypothesis is that IMHB may occur in hypertensivepatients in whom spontaneous bleeding of the vasa vaso-
rum will lead to the characteristic cresentic thickening of
the median layer, not affecting the intima, whereas
ABAD involves a tear in the intima of the aorta, allowing
blood to ﬂow within layers of the media.
We observed that IMHB patients were less often trans-
ferred to referring centers. The concept that IMHB repre-
sent a more stable clinical condition compared with ABAD
might contribute to the choice of physicians at tertiary
centers to manage these patients medically at their own
institution.
The clinical presentation of IMHB patients was compa-
rable with ABAD patients, although IMHB presented at an
older age and more often with chest pain. Although
complications like malperfusion were more frequently
present in ABAD patients, interestingly, ﬁve IMHB
patients presented with limb ischemia. Despite the focal
Table VI. Outcomes in IMHB and ABAD patients
Category
Type B
IMHB,
No. (%)
ABAD,
No. (%) P value
In-hospital mortality: 7 (7) 84 (11) .188
Medical management 6 (6) 44 (9) .413
Endovascular 0 (0) 17 (12) .413
Surgery within 24 hours
of presentation
0 (0) 6 (26) 1.000
Surgery after 24 hours 0 (0) 13 (17) 1.000
1-year follow-up
Follow-up available (% of total) 45 (42) 274 (35)
Mortality 4 (9) 19 (7) .547
Surgical management e
mortality
1 (33) 1 (3) .181
Cerebrovascular accident - - -
Rupture - - -
Reoperation 0 (0) 7 (9) .588
Aortic enlargement of
descending diameter
10 (39) 90 (61) .034
ABAD, Type B aortic dissection; IMHB, aortic intramural hematoma type B.
Table V. Management of IMHB and ABAD patients
Category
Type B
IMHB,
No. (%)
ABAD,
No. (%) P value
Medical management 94 (88) 491 (62) <.001
IMH e descending as reason
for medical management
68 (85) 52 (22) <.001
Beta-blockers at discharge 76 (91) 406 (92) .578
Angiotensin-converting enzyme
inhibitors at discharge
49 (59) 240 (58) .821
Angiotensin receptor blockers
at discharge
8 (24) 25 (19) .509
Calcium channel blockers at
discharge
49 (62) 275 (65) .611
Surgical management 5 (5) 112 (14) .005
Endovascular management 7 (7) 181 (23) <.001
Hybrid management 1 (1) 6 (1) .590
ABAD, Type B aortic dissection; IMHB, aortic intramural hematoma type B.
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obstruction of an aortic side branch, resulting in end-
organ ischemia and necessitating interventional therapy.17
Diagnostic imaging showed that periaortic hematoma
is more often present in IMHB patients. In this context,
the presence of pleural effusion can make it difﬁcult to
distinguish the outer section of the IMH and eventual
disruption of the aortic adventitia. Studies on aortic
pathology showed the close relationship of the hematoma
with the adventitia, making it more prone to periaortic
hematoma and rupture.11 During hospitalization, two
patients with periaortic hematoma died due to a frank
aortic rupture despite adequate medical treatment. This
observation conﬁrms the importance of periaortic hema-
toma as a risk factor for adverse outcome in IMHB
needing emergent intervention. However, in such
patients, it is essential to differentiate periaortic hematoma
from pleural effusion, which represents a reactive ﬂuid
collection in the chest and not a sign of impending aortic
rupture.12
In general, the course of IMHB is relatively stable, but
remains unpredictable. Some patients are stable for years or
develop spontaneous regression, while others will develop
complications such as a progressive aneurysm expansion,
aortic dissection, or even aortic rupture. To prevent such
complications, some physicians suggested that IMHB
patients may be treated prophylactically with a surgical
or endovascular intervention.10,15 However, because of
intervention-related complications, this strategy has not
widely been adopted, and a more complication-speciﬁc
approach, similar to the treatment of ABAD, was sug-
gested.15,17 Invasive intervention was performed in patients
who showed signs of aortic rupture or aortic enlargement,
with special caution in patients with landing zones not
located on a normal aortic wall. Generally, patients are
managed with a strict medical treatment with adequate
follow-up, and only in the presence of complications
will they receive an intervention. Nevertheless, despiteadequate medical treatment, six patients died in hospital,
two from rupture. These ﬁndings emphasize the impor-
tance of accurate control of blood pressure and close
imaging follow-up. Many predictors for the progression
of IMHB to aortic dissection have been proposed,
including increased initial aortic diameter, wall thickness,
and absence of beta-blockade. Unfortunately, the retro-
spective character of this study prohibited further analysis
of these patients, and none of these predictors could be
conﬁrmed.
Endovascular and surgical interventions were reserved
for patients presenting with complicated IMHB, which is
comparable to the treatment of ABAD.12 The focal char-
acter of the aortic lesion makes IMHB patients very suit-
able candidates for endovascular treatment, which should
be, as suggested by many reports, the therapy of ﬁrst choice
in complicated patients.15,17 In the present analysis, seven
patients were treated in this fashion, all with excellent
results. Hence, open surgical repair should be reserved
for complicated IMHB patients who cannot be treated
with stent graft placement, as in the presence of retrograde
aortic extension.
In IMHB patients, overall mortality during follow-up
was low at 9% after 1 year and was not aortic-related.9
Most interesting was that at 1-year follow-up, medical
therapy was maintained in the majority of the patients.
Because IRAD centers have a special interest in this
disease, this might contribute to improved medical
management. We believe that life-long medical therapy
is indicated for all patients with strict blood pressure
regulation.
This study represents one of the largest series to date,
but like all observational studies, several limitations should
be addressed. Imaging protocols and the type of computed
tomography scanner differed among centers, resulting in
signiﬁcant variation in imaging quality. Slice thickness,
Fig 2. Kaplan-Meier 5-year survival in aortic intramural hematoma type B (IMHB) and type B aortic dissection
(ABAD) patients.
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ability to distinguish between ABAD and IMHB.
However, diagnostic criteria are strict within IRAD, and
all images are evaluated by skilled physicians with a signiﬁ-
cant interest in aortic dissection. The IRAD database
consists of specialized referral centers, so it is conceivable
that this study population does not represent the common
patient population. Furthermore, available data on follow-
up are limited, especially regarding medical treatment. In
addition, mortality data available to us did not include
complete information on the exact cause of death for all
patients.
CONCLUSIONS
IHMB is a serious and rare disease with a relative
unpredictable course. Most IMHB patients have a more
limited extent of disease and can be treated medically. In
addition, aortic enlargement is less common during
follow-up, which may suggest that IMHmay have a slightly
more benign course compared with classic ABAD in the
acute setting. In the absence of suitable predictors for
high-risk patients, a complication-speciﬁc approach should
be adopted.
The authors would like to thank Dan Montgomery for
the statistical analysis.
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